Lung Cancer Clinical Trial
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
Summary
Phase 1b Dose Excalation/Expansion: Identify and characterize safety and tolerability of recommended phase 2 dose of CP-751,871 when administered with paclitaxel and carboplatin Phase 1b Erlotinib Extension: To characterize the safety and tolerability of CP751,871 when administered with paclitaxel, carboplatin and erlotinib.
Phase 2: To test the efficacy of CP-751,871 combined with paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer
Eligibility Criteria
Inclusion Criteria:
Diagnosis of advanced/metastatic lung cancer
Exclusion Criteria:
Previous treatment with chemotherapy
Uncontrolled diabetes
History/active cardiovascular disease
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 30 Locations for this study
Tucson Arizona, 85719, United States
Tucson Arizona, 85724, United States
Tucson Arizona, 85724, United States
Greenbrae California, 94904, United States
Los Angeles California, 90048, United States
Jacksonville Florida, 32216, United States
Jacksonville Florida, 32224, United States
Jeffersonville Indiana, 47130, United States
Louisville Kentucky, 40202, United States
Louisville Kentucky, 40207, United States
Louisville Kentucky, 40217, United States
Louisville Kentucky, 40241, United States
Shelbyville Kentucky, 40065, United States
Baltimore Maryland, 21204, United States
Rochester Minnesota, 55905, United States
Corinth Mississippi, 38834, United States
Southaven Mississippi, 38671, United States
Creve Coeur Missouri, 63141, United States
St. Louis Missouri, 63110, United States
St. Peters Missouri, 63376, United States
Bronx New York, 10461, United States
Bronx New York, 10467, United States
Philadelphia Pennsylvania, 19111, United States
Memphis Tennessee, 38104, United States
Memphis Tennessee, 38120, United States
Houston Texas, 77030, United States
Montreal Quebec, H3T 1, Canada
Orbassano (TO) , 10043, Italy
L'hospitalet de Llobregat Barcelona, 08907, Spain
Madrid , 28041, Spain
Sevilla , 41013, Spain
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.